Diabetes Screening Reminder for Women With Prior Gestational Diabetes A Randomized Controlled Trial

被引:21
|
作者
Zera, Chloe A.
Bates, David W.
Stuebe, Alison M.
Ecker, Jeffrey L.
Seely, Ellen W.
机构
[1] Brigham & Womens Hosp, Div Maternal Fetal Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gen Internal Med, Boston, MA 02115 USA
[4] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[5] Massachusetts Gen Hosp, Div Maternal Fetal Med, Dept Obstet & Gynecol, Boston, MA 02114 USA
[6] Univ N Carolina, Dept Obstet & Gynecol, Div Maternal Fetal Med, Sch Med, Chapel Hill, NC 27599 USA
来源
OBSTETRICS AND GYNECOLOGY | 2015年 / 126卷 / 01期
基金
美国国家卫生研究院;
关键词
MELLITUS; HISTORY;
D O I
10.1097/AOG.0000000000000883
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To evaluate whether an electronic health record (EHR) reminder improves rates of screening for type 2 diabetes in women with prior gestational diabetes. METHODS: We randomly allocated primary care providers (by clinic site) to a reminder for type 2 diabetes screening within the EHR or to usual care. Women with previous gestational diabetes mellitus were identified through an automated search of laboratory results and the problem list. We compared rates of screening during the study period (2010-2012) in women at intervention sites with those at control sites. With a sample size of 850 participants, we had 80% power to detect a 15% difference in screening rates. RESULTS: We included 847 individuals seen at a participating clinic during the study period, of whom 471 were at a reminder clinic and 376 were at a control clinic. A similar proportion of women were screened for type 2 diabetes in both groups (n=265, 56.3% of the reminder group compared with n=206, 54.8% of the control group, P=.67; adjusted odds ratio [OR] 1.04, 95% confidence interval [CI] 0.79-1.38). Patient characteristics associated with risk for diabetes including body mass index (adjusted OR per kg/m(2) 1.05, 95% CI 1.01-1.08) and race (adjusted OR for nonwhite race 2.14, 95% CI 1.57-2.92) were significantly associated with screening. CONCLUSION: A simple EHR reminder did not increase the rate of diabetes screening in women with prior gestational diabetes mellitus.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 50 条
  • [21] Postpartum diabetes screening in women with a history of gestational diabetes
    Smirnakis, KV
    Chasan-Taber, L
    Wolf, M
    Markenson, G
    Ecker, JL
    Thadhani, R
    OBSTETRICS AND GYNECOLOGY, 2005, 106 (06): : 1297 - 1303
  • [22] Postpartum Screening for Diabetes in Women with a History of Gestational Diabetes
    Rakhra, Varundeep
    Riley, Marcella
    Jordan, Symone
    Bulchandani, Sheetal
    Allsworth, Jenifer
    Drees, Betty
    DIABETES, 2021, 70
  • [23] Investigating screening for diabetes in women with a history of gestational diabetes
    Brink, H. S.
    Alkemade, M.
    van der Lely, A. J.
    van der Linden, J.
    NETHERLANDS JOURNAL OF MEDICINE, 2016, 74 (10): : 429 - 433
  • [24] Randomized controlled trial of intrapartum glucose management in women with gestational diabetes: NCT02596932
    Hamel, Maureen S.
    Kanno, Lindsey
    Has, Phinnara
    Beninati, Michael
    Rouse, Dwight J.
    Werner, Erika F.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (01) : S36 - S36
  • [25] Effects of selenium supplementation on glucose homeostasis in women with gestational diabetes mellitus: A randomized, controlled trial
    Najib, Fatemeh Sadat
    Poordast, Tahereh
    Nia, Mina Rezvan
    Dabbaghmanesh, Mohammad Hossein
    INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE, 2020, 18 (01) : 57 - 64
  • [26] A randomized controlled trial of a web-based education intervention for women with gestational diabetes mellitus
    Carolan-Olah, Mary
    Sayakhot, Padaphet
    MIDWIFERY, 2019, 68 : 39 - 47
  • [27] Performance characteristics of screening tests for type 2 diabetes in women with prior gestational diabetes: A systematic review
    Bennett, W. L.
    Bolen, S.
    Wilson, L. M.
    Bass, E. B.
    Nicholson, W. K.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 363 - 363
  • [28] "A Pragmatic, Randomized Clinical Trial of Gestational Diabetes Screening" - An Interdisciplinary Statement
    Schaefer-Graf, Ute Margaretha
    Adamczewski, Heinke
    Grieshop, Mellita
    Groten, Tanja
    Hummel, Michael
    Hummel, Sandra
    Kautzky-Willer, Alexandra
    Kuehnert, Maritta
    Laubner, Katharina
    Schild, Ralf
    Stupin, Jens H.
    Schmidt, Markus
    Weschenfelder, Friederike
    Abou-Dakn, Michael
    DIABETOLOGIE UND STOFFWECHSEL, 2021, 16 (05) : 369 - 371
  • [29] A Cluster Randomized Noninferiority Field Trial of Gestational Diabetes Mellitus Screening
    Tehrani, Fahimeh Ramezani
    Behboudi-Gandevani, Samira
    Farzadfar, Farshad
    Hosseinpanah, Farhad
    Hadaegh, Farzad
    Khalili, Davood
    Soleymani-Dodaran, Masoud
    Valizadeh, Majid
    Abedini, Mehrandokht
    Rahmati, Maryam
    Yarandi, Razieh Bidhendi
    Torkestani, Farahnaz
    Abdollahi, Zahra
    Bakhshandeh, Marzieh
    Zokaee, Mehdi
    Amiri, Mina
    Bidarpour, Farzam
    Javanbakht, Mehdi
    Nabipour, Iraj
    Esfahani, Ensieh Nasli
    Ostovar, Afshin
    Azizi, Fereidoun
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (07): : E2906 - E2920
  • [30] A randomized controlled trial of insulin detemir versus insulin NPH for the treatment of pregnant women with gestational diabetes and type 2 diabetes
    Herrera, Kimberly
    Rosenn, Barak
    Foroutan, Janelle
    Bimson, Brianne
    Al Ibraheemi, Zainab
    Brustman, Lois
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 212 (01) : S320 - S320